PDC Systems Ltd Competitors

ARCHER Systems, LLC (USA) provides pre-settlement and post- settlement administration services for single event, mass tort, and class action cases to help claimants access their settlement proceed more efficiently and quickly. The company plans to continue leveraging technology and top-tier talent to enhance customer service and offer new product lines and services. ARCHER's core offerings are post- -settlement Healthcare, Lien Resolution Administration and QSF (Qualified Settlement Fund) Administration and payments processing for multi-claimant (mass tort and class action) litigation. ARCHER Transnational Systems Pvt. Ltd. is a full owned subsidiary of ARCHER Systems, LLC (USA) ,operating as a Global Capability Center, plays a pivotal role in serving its parent company across a wide spectrum of functions. With a relentless commitment to excellence, ARCHER India ensures that the organization has access to the finest talent, equipped with the skills and knowledge needed to efficiently run the business. Through a combination of strategic initiatives, cutting-edge technologies, and a dedicated workforce, ARCHER India contributes significantly to the company's global success by fostering innovation, efficiency, and growth, ultimately driving the business to new heights on the global stage.

Skyvera offers powerful enterprise software solutions to help businesses gain a competitive edge in today’s fast-moving environment. All of the brands in our portfolio share a singular focus: helping customers achieve sustainable success. This is more than a talking point for our business. We gather feedback continually on how well we help customers achieve their goals. This keeps us laser-focused on what matters most to each individual customer. In addition to striving for 100% customer success, Skyvera is committed to: Transparency. We believe in communicating honestly with customers and delivering on realistic expectations. We strive to demonstrate our integrity and trustworthiness in every customer interaction. Vision. We monitor the evolution of technology and market behavior so we can provide forward-thinking solutions and operational improvements to customers every day. Stability. We believe there’s value in moving in step with marketplace trends without chasing after a risky cutting edge. By maintaining a strategic and disciplined focus, we ensure that we’ll be here to support our customers long-term with fresh, innovative solutions.

Tandem Labs (now Covance) is a leading bioanalytical service provider with cutting-edge technology and services focused on supporting small and large-molecule development efforts for discovery, pre-clinical and clinical studies. We strive to differentiate ourselves with our scientific expertise, responsive project management staff, structured method development, on-time metrics, and strong regulatory history. Our goal is to use our experience to make your job easier and to shorten your development timelines. Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading health care diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. Going forward, Tandem Labs and Covance will operate together under the Covance brand. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue in excess of $8 billion in 2013 and more than 48,000 employees in over 60 countries, LabCorp offers innovative solutions to healthcare stakeholders. LabCorp clients include physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs. To learn more about Covance Drug Development, visit www.covance.com.